Susan S Smyth
Overview
Explore the profile of Susan S Smyth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
3637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McMullen C, Williams M, Smyth S, Clouser J, Li J
PEC Innov
. 2023 May;
2:100131.
PMID: 37214525
Objective: The purpose of this study was to identify barriers and design interventions to promote adherence to 2017 Guideline for Syncope Evaluation and Management. Methods: Focus groups and interviews were...
2.
Tripathi H, Shindo K, Donahue R, Gao E, Kuppa A, Elkammar M, et al.
Arterioscler Thromb Vasc Biol
. 2022 Dec;
43(2):379-381.
PMID: 36453277
No abstract available.
3.
Zhang Y, Wu C, Li L, Pandeya A, Zhang G, Cui J, et al.
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35743244
Histones are cationic nuclear proteins that are essential for the structure and functions of eukaryotic chromatin. However, extracellular histones trigger inflammatory responses and contribute to death in sepsis by unknown...
4.
Smyth S, Coller B, Jackson R, Kern P, McIntosh S, Meagher E, et al.
J Clin Transl Sci
. 2022 Apr;
6(1):e34.
PMID: 35433037
Introduction: Identifying the most effective ways to support career development of early stage investigators in clinical and translational science should yield benefits for the biomedical research community. Institutions with Clinical...
5.
Van Hoose P, Yang L, Kraemer M, Ubele M, Morris A, Smyth S
Sci Rep
. 2022 Apr;
12(1):5664.
PMID: 35383201
Genetic variants that regulate lipid phosphate phosphatase 3 (LPP3) expression are risk factors for the development of atherosclerotic cardiovascular disease. LPP3 is dynamically upregulated in the context of vascular inflammation...
6.
Gorog D, Storey R, Gurbel P, Tantry U, Berger J, Chan M, et al.
Nat Rev Cardiol
. 2022 Jan;
19(7):475-495.
PMID: 35027697
Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and thromboembolic events, owing to excessive inflammation, endothelial cell activation and injury, platelet activation and hypercoagulability. Patients with COVID-19 have a prothrombotic...
7.
Amin S, Gupta V, Du G, McMullen C, Sirrine M, Williams M, et al.
J Med Internet Res
. 2021 Nov;
23(11):e25192.
PMID: 34783669
Background: Syncope evaluation and management is associated with testing overuse and unnecessary hospitalizations. The 2017 American College of Cardiology/American Heart Association (ACC/AHA) Syncope Guideline aims to standardize clinical practice and...
8.
Alnabelsi T, Faulkner S, Cook M, Freeman K, Shelton J, Paranzino M, et al.
Am J Emerg Med
. 2021 Aug;
50:202-206.
PMID: 34390903
Aim Of The Study: Targeted temperature management is a class I indication in comatose patients after a cardiac arrest. While the literature has primarily focused on innovative methods to achieve...
9.
Alnabelsi T, Annabathula R, Shelton J, Paranzino M, Faulkner S, Cook M, et al.
Resusc Plus
. 2021 Jul;
4:100039.
PMID: 34223316
Aim Of The Study: Most survivors of an in-hospital cardiac arrest do not leave the hospital alive, and there is a need for a more patient-centered, holistic approach to the...
10.
Li J, Smyth S, Clouser J, McMullen C, Gupta V, Williams M
Medicina (Kaunas)
. 2021 Jul;
57(6).
PMID: 34204986
Overuse and inappropriate use of testing and hospital admission are common in syncope evaluation and management. Though guidelines are available to optimize syncope care, research indicates that current clinical guidelines...